Calcium regulates the proliferation and differentiation of keratinocytes both in vivo and in vitro. Elevated extracellular Ca 2+ concentration ([Ca 2+ ] o ) raises the intracellular free calcium ([Ca 2+ ] i ) and activates differentiation-related genes. Cells lacking the calcium sensing receptor (CaR) fail to respond to [Ca 2+ ] o and to differentiate, indicating a role for CaR in keratinocyte differentiation. These concepts derived from in vitro experiments have been tested and confirmed in two mouse models.
keratinocytes is triggered by increasing the [Ca

2+
] o above 0.1 mM (8, 9, 11) . Elevation of [Ca 2+ ] o leads to characteristic morphological changes such as desmosome formation, stratification and cornification (12) (13) (14) . Calcium also induces the redistribution of protein kinase C (PKC ) (15, 16 ) and calmodulin to the plasma membrane where they augment the calcium signaling process.
These events are accompanied by a rearrangement of actin filaments from a perinuclear to a radial pattern (12) . The expression of biochemical markers in cultured keratinocytes is tightly regulated by [Ca 2+ ] o in the medium and follows a definite sequence, first the keratins K1 and K10, followed by involucrin, then transglutaminase I, and finally profilaggrin and loricrin (17) . Most of these differentiation-specific proteins are regulated at a transcriptional and, in some cases, at a post-translational level (e.g., transglutaminase I and profilaggrin) by [Ca 2+ ] o . These temporal changes in gene expression observed in vitro closely reflect the spatial changes in gene expression in the epidermis.
Calcium gradient in epidermis
Ion capture cytochemistry and proton-induced X-ray emission (PIXE) analyses have demonstrated the existence of a steep gradient of Ca 2+ in mouse and human epidermis (18) (19) (20) : Ca 2+ content is low in basal and spinous layers, whereas calcium levels increase progressively towards the outer stratum granulosum, and decreases again in the stratum corneum. Several studies indicated the importance of the calcium gradient for regulating epidermal function. First, perturbation in permeability barrier function leads to a decline in calcium levels in the outer epidermis and disruption of the epidermal calcium gradient (21) (22) (23) , which subsequently stimulates the secretion of preformed lamellar bodies from the outmost stratum granulosum cells 6 (24) . Normal calcium gradient is restored in 6-24 hours after barrier disruption in parallel with barrier recovery (21) (22) (23) (24) . Second, the formation of the Ca 2+ gradient coincides with key developmental milestones of barrier formation and stratum corneum development (20) . Finally, skin diseases characterized by an abnormal barrier, such as essential fatty acid deficiency and psoriasis, are accompanied by a loss of the calcium gradient (23, 25, 26) . Though the factors that form and maintain the Ca 2+ gradient in vivo are unknown; nevertheless, the pivotal role of calcium in epidermal differentiation is further supported by the observations that changes of Ca 2+ level in the outer epidermis, independent of barrier perturbation, directly regulate lamellar body secretion and the expression of differentiation-specific markers in vivo (27, 28) . ] o (53) .
Calcium signaling in the keratinocytes
The keratinocyte CaR sequence is identical to that of the parathyroid CaR. Besides the full-length CaR, keratinocytes produce an alternatively spliced variant of CaR. This spliced variant lacks exon 5, resulting in the loss of residues 460 to 536 in the extracellular domain (38) .
When cDNAs of full length CaR or its spliced variant were transfected into HEK 293 cells, the full length CaR was expressed as two major proteins of 140-kDa and 160-kDa, whereas the spliced variant of CaR was expressed as a single protein of 130-kDa (38, and ] o when they were coexpressed in HEK293 cells (38) , suggesting that the ratio of the two forms of CaR could be a factor regulating the calcium responsiveness in cells. Also, when both forms of CaR were cotransfected into keratinocytes with an involucrin promoter/luciferase gene construct, only the full-length CaR enhanced the calcium-stimulated induction of the involucrin gene ( The full-length CaR and its spliced variant are expressed differentially during keratinocyte differentiation. In Western analyses of keratinocyte membrane proteins (Fig. 3A) the endogenous CaR was detected by an antibody (ADDR) that reacts with both forms of CaR as three major bands of 120-kDa, 160-kDa and 185-kDa and a minor band of 130-kDa (which was best seen in longer exposed film). Whereas the 120-kDa band corresponds to the nonglycosylated full-length CaR, the 160-kDa band corresponds to one of the two major glycosylated forms (the 140-kDa and 160-kDa proteins) of full-length CaR (38) . An antibody (hCaR4/6) that specifically reacts with the human CaR splice variant confirmed the 130-kDa protein as the spliced variant (Fig. 3B) . The level of full-length CaR was higher in the less differentiated keratinocytes (5 days in culture) and decreased as the cells differentiated (Fig. 3A) , which is consistent with the larger [Ca] i and IP responses in undifferentiated cells. On the other hand, the level of the spliced variant remained relatively unaffected during keratinocyte differentiation (Fig. 3B) . The expression pattern of CaR message is similar to that of protein (38) .
In the parathyroid cells and in HEK293 cells ( Fig. 2A ) that were transfected with cDNA for the full-length CaR, CaR was extensively expressed on the plasma membrane, though substantial intracellular distribution was detected. On the other hand, in keratinocytes only a low level of the endogenous CaR protein is present on the plasma membrane, whereas the majority of the CaR protein is distributed within cytoplasm, especially in a perinuclear area. We have detected a considerable amount of CaR protein co-localized with the trans-golgi marker TGN38 (Fig. 4) . Substantial perinuclear cytoplasmic localization of CaR is commonly observed in other cell types (52, (54) (55) (56) 
Calcium receptor in mammalian epidermis
Immunocytochemistry and in situ hybridization confirmed the expression of CaR in mammalian skin (Fig. 5 ). An antibody recognizing both forms of CaR was used to detect the CaR protein in the human (Fig. 5A ) and mouse ( Fig. 5 B, C) epidermis. In both species the CaR protein is expressed in interfollicular suprabasal keratinocyte layers, whereas the keratinocytes in the basal layer contain little CaR. The strongest staining was observed in the cells of the upper stratum granulosum (Figs. 5A and B), whereas the corneocytes displayed weak staining.
Noticeably, most of the CaR staining was intracellular, not on the plasma membrane, confirming the distribution of CaR in cultured keratinocytes. The specificity of the staining was established as the peptide-preabsorbed antibody failed to react with CaR protein in mouse skin (Fig. 5C ). In situ hybridization using a DIG-labeled antisense RNA probe showed that the distribution of CaR message (Fig. 5D, E ) is similar to that of CaR protein in human (Fig. 5D ) and mouse (Fig. 5E) epidermis. While little or no CaR mRNA was seen in the basal layers of the interfollicular epidermis, the upper spinous and granular layers were labeled for CaR mRNA in both species.
Hybridization using a sense probe showed no signal in mouse skin (Fig. 5F ). These results demonstrated that the expression of CaR closely parallels the Ca 2+ gradient in the epidermis, supporting the concept that CaR mediates keratinocyte differentiation in vivo. However, the importance of CaR in the epidermis is made clear in two animal models, CaR deficient (Car-/-) mice (60) and transgenic mice with epidermal overexpression of CaR (61).
Calcium receptor deficient mice and calcium receptor transgenic mice
In the Car-/-mice the CaR gene was disrupted by insertion of a neomycin resistance gene into exon 5 (60) , which resulted in a complete loss of full-length CaR expression. However, immunocytochemistry, Western analyses, and in situ hybridization all detected the continuous expression of the alternatively spliced form of CaR in these animals (62, 63) . Previous studies (Fig. 6, left column) . Although the basal keratin expression (judged by the immunolocalization of K14, data not shown) did not change, the mRNA (Fig. 6A, B , E, F) and protein (Fig. 6C, D , G, H) levels of the terminal differentiation genes loricrin (Fig. 6 , A-D)and profilaggrin (Fig. 6, E Recently, Truksen and Troy (61) 
